TORONTO, Aug. 28, 2018 /CNW/ – TerrAscend Corp. (CSE:TER) (“TerrAscend” or the “Company”) is pleased to announce the appointment of Adam Kozak as Chief Financial Officer, effective August 27, 2018.
Mr Kozak brings with him a wealth of experience from Loblaw Companies Limited, where he was most recently Senior Director of Finance. During his tenure, Adam led initiatives in mergers and integration, process re-engineering and analytics.
Adam will be a tremendous addition to the executive management team at TerrAscend. His appointment will be instrumental in supporting the next stage of the Company’s corporate growth strategy. On behalf of our entire team and the Board of Directors, we thank our departing interim CFO, Roland Nimmo, for his commitment and contributions to TerrAscend and wish him continued success.
Michael Nashat, President and Chief Executive Officer
Incoming CFO, Adam Kozak remarked on his appointment, “TerrAscend’s distinction in a highly crowded market attracted me to the opportunity. The team has accomplished a great deal in their short time together. I’m thrilled to help the Company achieve its strategic goals.”
About TerrAscend
TerrAscend is a biopharmaceutical and wellness company that is committed to quality products, brands and services for the global cannabinoid market. The Company provides support to medical consumers through its wholly-owned subsidiaries, Solace Health Inc., a licensed producer of medical cannabis under the Access to Cannabis for Medical Purposes Regulations and Solace Health Network Inc., a clinical support program and education platform led by healthcare professionals.
